Practice Management

Understanding the impact that the beneficiary designation has on the payout of an individual retirement account after the IRA owner dies is a critical element of the planning process.

In this article, Robert A. Dowling, MD, examines some of the practice-related implications of the rapid change in the management of patients with advanced prostate cancer.

Other products featured include: Radiosurgery collimator allows treatment of broad rang of tumors and Phi prostate cancer test and more.

Products in the pipeline for prostate cancer, bladder cancer, and much more.

In this article, Robert A. Dowling, MD, discusses additional opportunities for urologists to improve the safety of care in their own practices in the context of the NQF best practices.

In this Coding Q&A column, the Painters discuss the tricky question of whether you can bill for stone prevention counseling, and also answer a question about whether you can bill two instillation codes (51700) for one appointment.

Other products featured include a spacer system to protect men undergoing PCa radiotherapy, a pelvic floor exercise app, and more.

If you continue to own appreciated capital assets until you or your spouse dies, the tax consequence could be greatly reduced, or maybe even completely eliminated, when the assets are eventually sold, courtesy of Section 1014(a) of the Internal Revenue Code, which generally allows an unlimited federal income tax basis step-up for appreciated capital assets owned by a person who passes away.

Although significant time is spent developing methods or strategies that come close to that “perfect investment," none is as popular or compelling as modern portfolio theory.

There appears to be a trend toward third-party patient financing options in the current environment.

We have never seen so many changes in coding and billing for any service that would equal the changes we’ve seen for reporting multiple stones in the urinary system. Over the past 3 years, we’ve witnessed multiple opinions and differing payment results.

In this article, I will discuss additional opportunities for urologists to improve the safety of care in their own practices in the context of the National Quality Forum’s best practices.

In cases involving a claim that a patient had an unnecessary operation where cancer was suspected but not found, the issues usually are a lack of informed consent and failure to further investigate the condition to get a definitive diagnosis.

In a series of articles, urologist Robert A. Dowling, MD, reviews aspects of the National Quality Forum's “Safe Practices for Better Healthcare” consensus recommendations that are relevant to quality and safety in urologic practice.

When choosing a life insurance product, time needs to be spent on the intricacies of how those death benefits pass to the intended heirs, and how your estate is impacted, prior to making the purchase.

The Painters clear up confusion surrounding coding for prostate needle biopsy, and also discuss split billing for urodynamics testing.

Neither option will sidestep the need for a manual review prior to payment, say Ray Painter, MD, and Mark Painter.

A patient with an abnormal PSA level transferred to another physician's care and was never told of his result. Two and a half years later, a biopsy revealed Gleason 9 prostate cancer.

To make sure you enjoy your retirement without financial worries, you should ensure you have enough money saved based on your own unique situation.

If you feel like the practice of medicine is becoming more complicated and that the government and the payers are out to get you, you are not alone, nor are you paranoid. In this article, we examine a few of the issues you are currently facing and some of the choices you have to make.

In this article, Robert A. Dowling, MD, covers some practical aspects of telemedicine and what it might mean for urology.

While it is often difficult to defend a case involving the removal of an organ for cancer that is then determined to be cancer free, the added claim of lack of informed consent for the procedure does not aid the defense in these lawsuits.

New products and services from Samsung Electronics America, Syneron Medical, American Medical Systems, New Star, Buffalo Filter, Cook Medical, Endo International, Trimel BioPharma Metamark, and the National Comprehensive Cancer Network.

Certain private payers are denying codes for prostate and renal biopsy, and strong documentation will be required to ensure you get paid for your services.

Urology Times looks back on the top health policy and practice management stories of 2014, including coverage of the Affordable Care Act and changes in reimbursement.

There is no specific limit to the number of times you can charge a –59 modifier. However, what and how you charge for multiple stones on the same side of the urinary tract is confusing, say Ray Painter, MD, and Mark Painter in their "Coding Q&A" column.

If your estate is substantial and you're concerned about the federal estate tax bill your heirs will pay, there's a way you might be able to use your house to remedy the situation. It may be as simple as giving away your home or as complex as knowing the mechanics of an estate-planning tool called a qualified personal residence trust.

In this article, Robert A. Dowling, MD, discusses some of the benefits, challenges, and evidence surrounding the patient portal.

Other products discussed in this article include a prosthesis for underactive bladder, a prostate cancer test, and an erectile dysfunction drug.

The 529 plan allows you to remove wealth from your estate while you steadily accumulate assets to help educate children, grandchildren, nieces, nephews, and even yourself, if you're planning to go back to college.